India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

▴ India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan
India is among the top ten countries in the world with respect to the number of patents filed.

Union Minister of Science and Technology, Earth Sciences and Health & Family Welfare, Dr Harsh Vardhan yesterday informed the DST-CII India Portugal Technology Summit 2020 which is a flagship event with Portugal as a partner country, “In India, about 30 vaccines are in different stages of development. Two of them are in the most advanced stage of development - COVAXIN developed through ICMR-Bharat Biotech collaboration and COVISHIELD from the Serum Institute of India. Both are in the Phase-III clinical trial stage. Our premier institution – the Indian Council of Medical Research-is involved in their trial executions. India is also hosting clinical trials for all the major vaccine contenders. Serum Institute of India, the world’s largest vaccine manufacturer, is conducting trials for the vaccine developed by Oxford University. ZydusCadila is also conducting a Ph2 trial of an indigenous DNA Vaccine. One of our pharma giants, Dr Reddy’s Laboratories, will distribute the Russian vaccine in India after conducting final-stage human trials and receiving regulatory approval”.

The Science & Technology Minister disclosed that India is among the top ten countries in the world with respect to the number of patents filed. Highlighting India’s efforts to fight the challenge of COVID, he said: “More than 100 start-ups supported by the Government have provided innovative products and solutions to overcome challenges posed by COVID-19”.

Dr Harsh Vardhan stated “The Summit is a reflection of the effective partnership between the Government and industry for developing a robust technology ecosystem for the country”. The Minister said, “The next iteration of this collaboration will be to encourage new solutions based on cutting edge technologies such as Machine Learning and Artificial Intelligence”.

He dwelt on India-Portugal relations in various fields over long years. Dr Harsh Vardhan expressed the hope that the interactions offer a good opportunity for the participating companies to explore prospects for bilateral investments across sectors such as healthcare, water, agriculture, energy and Information Technologies.

Prof Manuel Heitor, Minister of Science, Technology and Higher Education, Government of Portugal, who was the Guest of Honour delivered the Keynote Address. He said, “ These are times of solidarity. Our ties with India are strong. We need to rely on knowledge to be out of this crisis together”.

Prof. Ashutosh Sharma, Secretary, Department of Science and Technology (DST), Government of India, outlined that during all these years, the summit has facilitated co-creation of knowledge, two-way technology transfer, collaborative R&D projects and enhanced market access between India and the partner country’s industry and research institutes. He said that the S&T ecosystem has blossomed in India by the gradually increasing focus of its policy regime, an impetus that has been ably supported by the years of economic reforms and landmark initiatives.

Over the past 26 years, the Department of Science and Technology (DST), Government of India has been co-organizing the Technology Summit in partnership with Confederation of Indian Industry (CII). The summit has benefitted immensely the Indian industry and academic & research institutions by forging collaborations with global partners, including policymaking that has triggered the private sector’s investment in R&D and technology significantly. Spain, South Korea, the UK and Italy have also participated in the summits in the past.

Tags : #DrHarshVardhan #IndiaFightsCorona #LatestPharmaNews8thDec #LatestNewsonCOVIDVaccine8thDec #ICMR-Bharat-Biotech #ZydusCadila #DrReddysLab

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024